MARKET

IDXG

IDXG

Interpace Biosciences
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.28
+0.09
+1.10%
Closed 19:58 01/21 EST
OPEN
8.28
PREV CLOSE
8.19
HIGH
8.43
LOW
7.98
VOLUME
50.59K
TURNOVER
--
52 WEEK HIGH
11.16
52 WEEK LOW
3.810
MARKET CAP
31.63M
P/E (TTM)
-0.1376
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of IDXG and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

IDXG News

  • Oppenheimer Maintains Outperform on Interpace Biosciences, Raises Price Target to $17
  • Benzinga.5d ago
  • Interpace Biosciences executes 1:10 reverse split
  • seekingalpha.6d ago
  • Interpace Biosciences Sells $20M of Series B Preferred Stock to 1315 Capital and Ampersand Capital Partners
  • Benzinga.01/13 12:02
  • Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners
  • GlobeNewswire.01/13 11:55

More

Industry

Managed Health care
+0.50%
Healthcare Providers & Services
+0.22%

Hot Stocks

Name
Price
%Change

About IDXG

Interpace Biosciences, Inc., formerly Interpace Diagnostics Group, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, it provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.
More

Webull offers Interpace Biosciences Inc (IDXG) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.